48 research outputs found
Bone-anchored hearing implant surgery: our experience with linear incision and punch techniques.
Monoclinic and Orthorhombic NaMnO2 for Secondary Batteries: A Comparative Study
In this manuscript, we report a detailed physico-chemical comparison between the - and
-polymorphs of the NaMnO2 compound, a promising material for application in positive electrodes
for secondary aprotic sodium batteries. In particular, the structure and vibrational properties, as
well as electrochemical performance in sodium batteries, are compared to highlight differences and
similarities. We exploit both laboratory techniques (Raman spectroscopy, electrochemical methods)
and synchrotron radiation experiments (Fast-Fourier Transform Infrared spectroscopy, and X-ray
diffraction). Notably the vibrational spectra of these phases are here reported for the first time in the
literature as well as the detailed structural analysis from diffraction data. DFT+U calculations predict
both phases to have similar electronic features, with structural parameters consistent with the experimental
counterparts. The experimental evidence of antisite defects in the beta-phase between sodium
and manganese ions is noticeable. Both polymorphs have been also tested in aprotic batteries by comparing
the impact of different liquid electrolytes on the ability to de-intercalated/intercalate sodium
ions. Overall, the monoclinic -NaMnO2 shows larger reversible capacity exceeding 175 mAhg-1 at
10 mAg-1
Inositol and Non-Alcoholic Fatty Liver Disease: A Systematic Review on Deficiencies and Supplementation
Liver lipid accumulation is a hallmark of non-alcoholic fatty liver disease (NAFLD), broadly associated with insulin resistance. Inositols (INS) are ubiquitous polyols implied in many physiological functions. They are produced endogenously, are present in many foods and in dietary supplements. Alterations in INS metabolism seems to play a role in diseases involving insulin resistance such as diabetes and polycystic ovary syndrome. Given its role in other metabolic syndromes, the hypothesis of an INS role as a supplement in NAFLD is intriguing. We performed a systematic review of the literature to find preclinical and clinical evidence of INS supplementation efficacy in NAFLD patients. We retrieved 10 studies on animal models assessing Myoinosiol or Pinitol deficiency or supplementation and one human randomized controlled trial (RCT). Overall, INS deficiency was associated with increased fatty liver in animals. Conversely, INS supplementation in animal models of fatty liver reduced hepatic triglycerides and cholesterol accumulation and maintained a normal ultrastructural liver histopathology. In the one included RCT, Pinitol supplementation obtained similar results. Pinitol significantly reduced liver fat, post-prandial triglycerides, AST levels, lipid peroxidation increasing glutathione peroxidase activity. These results, despite being limited, indicate the need for further evaluation of INS in NAFLD in larger clinical trials
Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis B
The involvement of HBV DNA integration in promoting hepatocarcinogenesis and the extent to which the intrahepatic HBV reservoir modulates liver disease progression remains poorly understood. We examined the intrahepatic HBV reservoir, the occurrence of HBV DNA integration and its impact on the hepatocyte transcriptome in hepatitis B 'e' antigen (HBeAg)-negative chronic hepatitis B (CHB)
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets
Chronic HBV + HDV infection is associated with greater risk of liver fibrosis, earlier hepatic decompensation, and liver cirrhosis hepatocellular carcinoma compared to HBV mono-infection. However, to-date no direct anti-HDV drugs are available in clinical practice. Here, we identified conserved and variable regions in HBsAg and HDAg domains in HBV + HDV infection, a critical finding for the design of innovative therapeutic agents. The extent of amino-acid variability was measured by Shannon-Entropy (Sn) in HBsAg genotype-D sequences from 31 HBV + HDV infected and 62 HBV mono-infected patients (comparable for demographics and virological-parameters), and in 47 HDAg genotype-1 sequences. Positions with Sn = 0 were defined as conserved. The percentage of conserved HBsAg-positions was significantly higher in HBV + HDV infection than HBV mono-infection (p = 0.001). Results were confirmed after stratification for HBeAg-status and patients’ age. A Sn = 0 at specific positions in the C-terminus HBsAg were correlated with higher HDV-RNA, suggesting that conservation of these positions can preserve HDV-fitness. Conversely, HDAg was characterized by a lower percentage of conserved-residues than HBsAg (p < 0.001), indicating higher functional plasticity. Furthermore, specific HDAg-mutations were significantly correlated with higher HDV-RNA, suggesting a role in conferring HDV replicative-advantage. Among HDAg-domains, only the virus-assembly signal exhibited a high genetic conservation (75% of conserved-residues). In conclusion, HDV can constrain HBsAg genetic evolution to preserve its fitness. The identification of conserved regions in HDAg poses the basis for designing innovative targets against HDV-infection
Autophagy and Inflammasome Activation in Dilated Cardiomyopathy
Background: The clinical outcome of patients affected by dilated cardiomyopathy (DCM) is heterogeneous, since its pathophysiology is only partially understood. Interleukin 1 beta levels could predict the mortality and necessity of cardiac transplantation of DCM patients. Objective: To investigate mechanisms triggering sterile inflammation in dilated cardiomyopathy (DCM). Methods: Hearts explanted from 62 DCM patients were compared with 30 controls, employing immunohistochemistry, cellular and molecular biology, as well as metabolomics studies. Results: Although misfolded protein accumulation and aggresome formation characterize DCM hearts, aggresomes failed to trigger the autophagy lysosomal pathway (ALP), with consequent accumulation of both p62(SQSTM1) and dysfunctional mitochondria. In line, DCM hearts are characterized by accumulation of lipoperoxidation products and activation of both redox responsive pathways and inflammasome. Consistently with the fact that mTOR signaling may impair ALP, we observed, an increase in DCM activation, together with a reduction in the nuclear localization of Transcription Factor EB -TFEB- (a master regulator of lysosomal biogenesis). These alterations were coupled with metabolomic alterations, including accumulation of branched chain amino acids (BCAAs), known mTOR activators. Consistently, reduced levels of PP2Cm, a phosphatase that regulates the key catabolic step of BCAAs, coupled with increased levels of miR-22, a regulator of PP2Cm levels that triggers senescence, characterize DCM hearts. The same molecular defects were present in clinically relevant cells isolated from DCM hearts, but they could be reverted by downregulating miR-22. Conclusion: We identified, in human DCM, a complex series of events whose key players are miR-22, PP2Cm, BCAA, mTOR, and ALP, linking loss of proteostasis with inflammasome activation. These potential therapeutic targets deserve to be further investigated
Systemic distribution of single-walled carbon nanotubes in a novel model: alteration of biochemical parameters, metabolic functions, liver accumulation, and inflammation in vivo
Editorial: Toxicological profiles and pharmacological properties of synthetic cannabinoids: From chemical and analytical issues to fatal and non-fatal intoxications
Since the discovery of the cannabinoid receptors in the central nervous system (CNS), that mediate the psychotropic effect of cannabis, a multitude of synthetic cannabinoid receptor agonists (SCRAs) has been developed to explore and probe the endocannabinoid system and to gather information on their potential therapeutic use. Prompted by the possibility of treating cancer pain and inflammatory diseases with cannabis, cannabinoid receptor ligands and in particular agonists started being synthetized as potential drug candidates. While in most cases not progressing to clinical trials, SCRAs have become a rapidly growing class of drugs of abuse, within the wider context of the new psychoactive substances (NPS) phenomenon. The first detection of SCRAs in herbal blends and “Spice” products dates back to 2008 (1) and, since then, they came into the focus of attention in the general public and particularly in the forensic science community. Although the number of new compounds per year monitored by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) slightly decreased since 2014-2015 (2), SCRAs still represent a serious public health and social issue
Lipid rafts as viral entry routes and immune platforms: A double-edged sword in SARS-CoV-2 infection?
Lipid rafts are nanoscopic compartments of cell membranes that serve a variety of biological functions. They play a crucial role in viral infections, as enveloped viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can exploit rafts to enter or quit target cells. On the other hand, lipid rafts contribute to the formation of immune synapses and their proper functioning is a prerequisite for adequate immune response and viral clearance. In this narrative review we dissect the panorama focusing on this singular aspect of cell biology in the context of SARS-CoV-2 infection and therapy. A lipid raft-mediated mechanism can be hypothesized for many drugs recommended or considered for the treatment of SARS-CoV-2 infection, such as glucocorticoids, antimalarials, immunosuppressants and antiviral agents. Furthermore, the additional use of lipid-lowering agents, like statins, may affect the lipid composition of membrane rafts and thus influence the processes occurring in these compartments. The combination of drugs acting on lipid rafts may be successful in the treatment of more severe forms of the disease and should be reserved for further investigation
When Design Met Law: Design Patterns for Information Transparency
The problems of online disclosures, notices, and terms are well-known and documented. Research and experience tell us that consumers dislike and do not read them. Much less has been said and done about the solutions. Building on Proactive Law and Legal Design, this research-based, practice-oriented article introduces proactive legal design patterns as a possible way forward. The article illustrates, with examples, how design patterns can help implement the principle of transparency in consumer-facing communication and elaborates, in an innovative manner, the ways in which legal design patterns can help solve recurring problems